Can the retail-Pharma giant convey in 2025?

CVS Health Corporation (NYSE:CVS) is included between The best Pharma Dividend Shares to get in 2025.

Demonstrates a number of shelves in the retail pharmacy, diversity and extreme products of drugs.

CVS Health Corporation (NYSE: CVS) ‘s retail pharmaceutical business can be widely recognized, but represents a small part of a wider work. The company also owns a marvest pharmacy benefits management department and AETNA in a highest level in the health insurance space.

CVS Health Corporation (NYSE: CVS) Association has taken a significant hit last year, but withdrew this year. The stock has been more than 43% since 2025. The company, in the first quarter of 2025, is $ 94.6 billion in revenues. The income showed 7% of the same period last year and defeated the estimates of analysts at $ 1.22 billion.

CVS Health Corporation (NYSE: CVS) also placed a solid money position of the operation cash flow $ 4.6 billion. The company increased the cash flow forecast for about $ 7.5 billion. This money position has provided the company’s continuous dividends since 1997.

When we accept the potential of CVs as an investment, we believe that certain AI shares offer greater potential and lower risk. If you are looking for an extremely worthless AI Stock to take advantage of the Trump-ERA tariffs and onhoring trends, please see our free report The best short-term EU reserve.

Read the next: 13 Best Industrial Dividend Shares to Buy Currently and The best passive income stock to get now.

Disclosure: No.